10X GENOMICS INC-CLASS A (TXG) Stock Earnings & Estimates
USA - NASDAQ:TXG - US88025U1097 - Common Stock
13.71 USD
-0.06 (-0.44%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 516.4M 5.28% | 618.727M 19.82% | 610.785M -1.28% | 623.4M 2.07% | 612.45M -1.76% | 675.98M 10.37% | 732.22M 8.32% | 750.18M 2.45% | 861.53M 14.84% | 936.57M 8.71% | 1.246B 33.04% | |
| EBITDA YoY % growth | -142.53M -357.12% | -151.33M -6.17% | -148.751M 1.70% | -76.55M 48.54% | -90.601M -18.36% | -58.37M 35.57% | -44.44M 23.87% | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -167.9M -221.03% | -194.949M -16.11% | -192.459M 1.28% | -81.723M 57.54% | -130.186M -59.30% | -80.24M 38.37% | -78.831M 1.76% | -125.695M -59.45% | -95.142M 24.31% | -58.075M 38.96% | 59.186M 201.91% | |
| Operating Margin | -32.51% | -31.51% | -31.51% | -13.11% | -21.26% | -11.87% | -10.77% | -16.76% | -11.04% | -6.20% | 4.75% | |
| EPS YoY % growth | -1.47 -182.69% | -2.17 -47.62% | -1.52 29.95% | -0.62 59.51% | -0.95 -55.02% | -0.63 34.39% | -0.10 83.86% | 0.12 220.00% | 0.34 183.33% | N/A | N/A |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.29 2.61% | -0.25 36.73% | -0.29 19.37% | -0.24 -184.93% | -0.24 17.35% | -0.19 23.44% | -0.22 23.45% | -0.22 8.69% | -0.20 16.35% | -0.14 29.62% |
| Revenue Q2Q % growth | 143.91M -5.11% | 152.56M -7.55% | 145.8M -5.86% | 151.45M -12.41% | 153.41M 6.60% | 162.56M 6.55% | 150.48M 3.21% | 155.57M 2.72% | 160.05M 4.33% | 176.52M 8.59% |
| EBITDA Q2Q % growth | -30.937M -270.90% | -25.179M -310.68% | -24.659M 36.31% | -19.949M -324.37% | -20.787M 32.81% | -15.707M 37.62% | -23.922M 2.99% | -23.255M -16.58% | -21.962M -5.65% | -12.756M 18.79% |
| EBIT Q2Q % growth | -27.054M 34.78% | -33.308M 33.17% | -38.846M 19.95% | -33.336M -215.26% | -33.458M -23.67% | -27.871M 16.32% | -29.24M 24.73% | -28.356M 14.94% | -26.967M 19.40% | -17.604M 36.84% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 0.28 187.50% | -0.38 | 0.66 | 174.61% |
| Q1 2025 Q2Q % growth | -0.36 28.00% | -0.48 | 0.12 | 24.36% |
| Q4 2024 Q2Q % growth | -0.40 2.44% | -0.30 | -0.10 | -34.43% |
| Q3 2024 Q2Q % growth | -0.30 62.03% | -0.35 | 0.05 | 13.04% |
| Q2 2024 Q2Q % growth | -0.32 39.62% | -0.48 | 0.16 | 33.83% |
| Q1 2024 Q2Q % growth | -0.50 -13.64% | -0.51 | 0.01 | 1.07% |
| Q4 2023 Q2Q % growth | -0.41 -173.33% | -0.36 | -0.05 | -13.26% |
| Q3 2023 Q2Q % growth | -0.79 -113.51% | -0.46 | -0.33 | -70.21% |
| Q2 2023 Q2Q % growth | -0.53 7.02% | -0.41 | -0.12 | -30.01% |
| Q1 2023 Q2Q % growth | -0.44 -15.79% | -0.38 | -0.06 | -16.54% |
| Q4 2022 Q2Q % growth | -0.15 6.25% | -0.31 | 0.16 | 52.34% |
| Q3 2022 Q2Q % growth | -0.37 -146.67% | -0.47 | 0.10 | 21.05% |
| Q2 2022 Q2Q % growth | -0.57 -470.00% | -0.39 | -0.18 | -45.45% |
| Q1 2022 Q2Q % growth | -0.38 -245.45% | -0.32 | -0.06 | -20.32% |
| Q4 2021 Q2Q % growth | -0.16 95.87% | -0.09 | -0.07 | -83.39% |
| Q3 2021 Q2Q % growth | -0.15 76.92% | -0.20 | 0.05 | 26.60% |
| Q2 2021 Q2Q % growth | -0.10 75.61% | -0.26 | 0.16 | 61.95% |
| Q1 2021 Q2Q % growth | -0.11 45.00% | -0.28 | 0.17 | 60.14% |
| Q4 2020 Q2Q % growth | -3.87 -5,428.57% | -0.23 | -3.64 | -1,584.26% |
| Q3 2020 Q2Q % growth | -0.65 -96.97% | -0.31 | -0.34 | -110.91% |
| Q2 2020 Q2Q % growth | -0.41 | -0.56 | 0.15 | 26.55% |
| Q1 2020 Q2Q % growth | -0.20 | -0.13 | -0.07 | -49.34% |
| Q4 2019 Q2Q % growth | -0.07 | -0.11 | 0.04 | 38.80% |
| Q3 2019 Q2Q % growth | -0.33 | -0.12 | -0.21 | -172.28% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 172.908M 12.93% | 140.83M | 32.078M | 22.78% |
| Q1 2025 Q2Q % growth | 154.883M 9.84% | 133.78M | 21.103M | 15.77% |
| Q4 2024 Q2Q % growth | 165.021M -10.30% | 160.98M | 4.041M | 2.51% |
| Q3 2024 Q2Q % growth | 151.654M -1.30% | 160.22M | -8.566M | -5.35% |
| Q2 2024 Q2Q % growth | 153.104M 4.28% | 151.59M | 1.514M | 1.00% |
| Q1 2024 Q2Q % growth | 141.006M 5.01% | 143.67M | -2.664M | -1.85% |
| Q4 2023 Q2Q % growth | 183.979M 17.78% | 184.63M | -651K | -0.35% |
| Q3 2023 Q2Q % growth | 153.644M 17.20% | 152.78M | 864K | 0.57% |
| Q2 2023 Q2Q % growth | 146.819M 28.11% | 141.36M | 5.459M | 3.86% |
| Q1 2023 Q2Q % growth | 134.285M 17.28% | 130.11M | 4.175M | 3.21% |
| Q4 2022 Q2Q % growth | 156.2M 8.85% | 149.65M | 6.55M | 4.38% |
| Q3 2022 Q2Q % growth | 131.1M 4.63% | 130.87M | 230K | 0.18% |
| Q2 2022 Q2Q % growth | 114.6M -1.04% | 118.37M | -3.77M | -3.18% |
| Q1 2022 Q2Q % growth | 114.5M 8.22% | 114.48M | 20K | 0.02% |
| Q4 2021 Q2Q % growth | 143.5M 27.90% | 150.02M | -6.52M | -4.35% |
| Q3 2021 Q2Q % growth | 125.3M 74.51% | 123.84M | 1.46M | 1.18% |
| Q2 2021 Q2Q % growth | 115.8M 169.93% | 113.98M | 1.82M | 1.60% |
| Q1 2021 Q2Q % growth | 105.8M 47.15% | 103.53M | 2.27M | 2.19% |
| Q4 2020 Q2Q % growth | 112.2M 49.00% | 101.41M | 10.79M | 10.64% |
| Q3 2020 Q2Q % growth | 71.8M 17.32% | 61.838M | 9.962M | 16.11% |
| Q2 2020 Q2Q % growth | 42.9M -23.12% | 29.856M | 13.044M | 43.69% |
| Q1 2020 Q2Q % growth | 71.9M 34.14% | 74.159M | -2.259M | -3.05% |
| Q4 2019 Q2Q % growth | 75.3M | 70.7M | 4.6M | 6.51% |
| Q3 2019 Q2Q % growth | 61.2M | 55.446M | 5.754M | 10.38% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.27% | 0.97% | -1.92% | 49.59% |
| Revenue | -0.03% | -0.83% | -0.08% | 4.71% |